Study Summary
This is a a phase 1, open label study to assess the safety and efficacy of ThisCART19 (Allogeneic CAR-T targeting CD19) Bridging Hematopoietic Stem Cell Transplantation in patients with refractory or relapsed B cell acute lymphoblastic leukemia (r/r B-ALL).
Want to learn more about this trial?
Request More InfoInterventions
ThisCART19ADRUG
ThisCART19A is a new type CAR-T therapy for patients with r/r B-ALL.
Fludarabine Oral TabletDRUG
Fludarabine is used for lymphodepletion.
CyclophosphamideDRUG
Cyclophosphamide is used for lymphodepletion.
VP-16DRUG
VP-16 is used for lymphodepletion.
HSCTPROCEDURE
Hematological stem cell transplantation
Study Locations
No locations listed.